A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
- Status
- RECRUITING
- Phase
- PHASE2
Related studies linked through entity extraction aliases.